Zhui Chen
Fondateur chez ABBISKO CAYMAN LIMITED
Fortune : 8 M $ au 30/06/2024
Profil
Zhui Chen is the founder of Abbisko Therapeutics Co., Ltd.
and Abbisko Cayman Ltd., both founded in 2016.
He is currently a Director at Abbisko Hong Kong Ltd.
since 2018 and a Member of the American Association for Cancer Research since 2007.
He was previously an Associate Director at Johnson & Johnson China Ltd.
from 2014 to 2016.
Dr. Chen received his doctorate degree from Duke University in 2003 and his undergraduate degree from The University of Texas at Austin in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ABBISKO CAYMAN LIMITED
2,63% | 02/04/2024 | 18 490 051 ( 2,63% ) | 8 M $ | 30/06/2024 |
Postes actifs de Zhui Chen
| Sociétés | Poste | Début |
|---|---|---|
| ABBISKO CAYMAN LIMITED | Fondateur | 12/04/2016 |
Abbisko Therapeutics Co., Ltd.
 Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Fondateur | 12/04/2016 |
| Abbisko Hong Kong Ltd. | Directeur/Membre du Conseil | 01/03/2018 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01/01/2007 |
Anciens postes connus de Zhui Chen
| Sociétés | Poste | Fin |
|---|---|---|
Johnson & Johnson China Ltd.
 Johnson & Johnson China Ltd. Pharmaceuticals: MajorHealth Technology Part of Kenvue, Inc., Johnson & Johnson China Ltd. is a Chinese company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Corporate Officer/Principal | 01/05/2016 |
Formation de Zhui Chen
| The University of Texas at Austin | Undergraduate Degree |
| Duke University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABBISKO CAYMAN LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
Abbisko Therapeutics Co., Ltd.
Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Health Technology |
Johnson & Johnson China Ltd.
Johnson & Johnson China Ltd. Pharmaceuticals: MajorHealth Technology Part of Kenvue, Inc., Johnson & Johnson China Ltd. is a Chinese company that manufactures pharmaceutical products. The company is based in Shanghai, China. | Health Technology |
| Abbisko Hong Kong Ltd. | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
